Enhancing the apoptotic potential of insulin-like growth factor-binding protein-3 in prostate cancer by modulation of CK2 phosphorylation

Molecular Endocrinology

Volumn 23, Issue 10, 2009, Pages 1624-1633

  Cobb, Laura J ^a   Mehta, Hemal ^a   Cohen, Pinchas ^a,b  

^a MATTEL CHILDREN S HOSPITAL   (United States)

^b MDCC 22 315 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; SMALL INTERFERING RNA; SOMATOMEDIN BINDING PROTEIN 3;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER THERAPY; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; REGULATORY MECHANISM; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CASEIN KINASE II; CELL LINE, TUMOR; CELL NUCLEUS; CELL SURVIVAL; DNA-ACTIVATED PROTEIN KINASE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; ORGAN SPECIFICITY; PHOSPHORYLATION; PHOSPHOSERINE; PROSTATIC NEOPLASMS; PROTEIN TRANSPORT;

EID: 70349766917     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2008-0365     Document Type: Article

References (43)

1. Firth SM, Baxter RC 2002 Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854 (Pubitemid 35454590)
2. Rajah R, Valentinis B, Cohen P 1997 Insulin-like growth factor (IGF)- binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 272:12181-12188 (Pubitemid 27202802)
3. Kim HS, Ingermann AR, Tsubaki J, Twigg SM, Walker GE, Oh Y 2004 Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells. Cancer Res 64:2229-2237 (Pubitemid 38339477)
4. Gucev Z, Oh Y, Kelley KM, Rosenfeld RG 1996 Insulin-like growth factor-binding protein 3 mediates retinoic acid- and transforming growth factor β2-induced growth inhibition in human breast cancer cells. Cancer Res 56:1545-1550 (Pubitemid 26104017)
5. Schedlich LJ, Le Page SL, Firth SM, Briggs LJ, Jans DA, Baxter RC 2000 Nuclear import of insulin-like growth factor-binding protein- 3 and -5 is mediated by the importin β subunit. J Biol Chem 275:23462-23470
6. Lee KW, Liu B, Ma L, Li H, Bang P, Koeffler HP, Cohen P 2004 Cellular internalization of insulin-like growth factor-binding protein- 3: distinct endocytic pathways facilitate re-uptake and nuclear localization. J Biol Chem 279:469-476 (Pubitemid 38044848)
7. Schedlich LJ, Young TF, Firth SM, Baxter RC 1998 Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem 273:18347-18352
8. Liu B, Lee HY, Weinzimer SA, Powell DR, Clifford JL, Kurie JM, Cohen P 2000 Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-α regulate transcriptional signaling and apoptosis. J Biol Chem 275:33607-33613 (Pubitemid 30808578)
9. Butt AJ, Fraley KA, Firth SM, Baxter RC 2002 IGF-binding protein- 3-induced growth inhibition and apoptosis do not require cell surface binding and nuclear translocation in human breast cancer cells. Endocrinology 143:2693-2699
10. Zappala G, Elbi C, Edwards J, Gorenstein J, Rechler MM, Bhattacharyya N 2008 Induction of apoptosis in human prostate cancer cells by insulin-like growth factor binding protein-3 does not require binding to retinoid X receptor-α. Endocrinology 149:1802-1812
11. Cobb LJ, Liu B, Lee KW, Cohen P 2006 Phosphorylation by DNA-dependent protein kinase is critical for apoptosis induction by insulin-like growth factor binding protein-3. Cancer Res 66:10878-10884 (Pubitemid 44876985)
12. Hoeck WG, Mukku VR 1994 Identification of the major sites of phosphorylation in IGF binding protein-3. J Cell Biochem 56:262-273
13. Coverley JA, Martin JL, Baxter RC 2000 The effect of phosphorylation by casein kinase 2 on the activity of insulin-like growth factor-binding protein-3. Endocrinology 141:564-570
14. Ahmed K, Gerber DA, Cochet C 2002 Joining the cell survival squad: an emerging role for protein kinase CK2. Trends Cell Biol 12:226-230 (Pubitemid 34327615)
15. Hollowood AD, Stewart CE, Perks CM, Pell JM, Lai T, Alderson D, Holly JM 2002 Evidence implicating a mid-region sequence of IGFBP-3 in its specific IGF-independent actions. J Cell Biochem 86:583-589 (Pubitemid 36076174)
16. Szyszka R, Grankowski N, Felczak K, Shugar D 1995 Halogenated benzimidazoles and benzotriazoles as selective inhibitors of protein kinases CK-I and CK-II from Saccharomyces cerevisiae and other sources. Biochem Biophys Res Commun 208:418-424
17. Pagano MA, Meggio F, Ruzzene M, Andrzejewska M, Kazimierczuk Z, Pinna LA 2004 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2. Biochem Biophys Res Commun 321:1040-1044
18. Wang G, Ahmad KA, Ahmed K 2006 Role of protein kinase CK2 in the regulation of tumor necrosis-factor-related apoptosis inducing ligand-induced apoptosis in prostate cancer cells. Cancer Res 66:2242-2249 (Pubitemid 43294936)
19. Götz C, Bachmann C, Montenarh M 2007 Inhibition of protein kinase CK2 leads to a modulation of androgen receptor dependent transcription in prostate cancer cells. Prostate 67:125-134 (Pubitemid 46185315)
20. Oh Y, Müller HL, Ng L, Rosenfeld RG 1995 Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J Biol Chem 270:13589-13592
21. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P 1995 The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 9:361-367
22. Gill ZP, Perks CM, Newcomb PV, Holly JM 1997 Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner. J Biol Chem 272:25602-25607
23. Lee HY, Chun KH, Liu B, Wiehle SA, Cristiano RJ, Hong WK, Cohen P, Kurie JM 2002 Insulin-like growth factor binding protein- 3 inhibits the growth of non-small cell lung cancer. Cancer Res 62:3530-3537 (Pubitemid 34651404)
24. Williams AC, Collard TJ, Perks CM, Newcomb P, Moorghen M, Holly JMP, Paeaskeva C 2000 Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells. Cancer Res 60:20-27 (Pubitemid 30058723)
25. Bhattacharyya N, Pechhold K, Shahjee H, Zappala G, Elbi C, Raaka B, Wiench M, Hong J, Rechler MM 2006 Nonsecreted insulin-like growth factor binding protein-3 (IGFBP-3) can induce apoptosis in human prostate cancer cells by IGF-independent mechanisms without being concentrated in the nucleus. J Biol Chem 281:24588-24601 (Pubitemid 44274233)
26. Lee KW, Cobb LJ, Paharkova-Vatchkova V, Liu B, Milbrandt J, Cohen P 2007 Contribution of the orphan nuclear receptor Nur77 to the apoptotic action of IGFBP-3. Carcinogenesis 28:1653-1658 (Pubitemid 47289026)
27. Lees-Miller SP, Godbout R, Chan DW, Weinfeld M, Day 3rd RS, Barron GM, Allalunis-Turner J 1995 Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science 267:1183-1185
28. Mannhardt B, Weinzimer SA, Wagner M, Fiedler M, Cohen P, Jansen-Dürr P, Zwerschke W 2000 Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3. Mol Cell Biol 20:6483-6495 (Pubitemid 30650235)
29. Oufattole M, Lin SW, Liu B, Mascarenhas D, Cohen P, Rodgers BD 2006 Ribonucleic acid polymerase II binding subunit 3 (Rpb3), a potential nuclear target of insulin-like growth factor binding protein- 3. Endocrinology 147:2138-2146
30. Jones JI, D'Ercole AJ, Camacho-Hubner C, Clemmons DR 1991 Phosphorylation of insulin-like growth factor (IGF)-binding protein- 1 in cell culture and in vivo: effects on affinity for IGF. Proc Natl Acad Sci USA 88:7481-7485
31. Westwood M, Gibson JM, White A 1997 Purification and characterization of the insulin-like growth factor binding protein-1 phosphoform found in normal plasma. Endocrinology 138:1130-1136 (Pubitemid 27089770)
32. Mishra S, Murphy LJ 2003 Phosphorylation of insulin-like growth factor (IGF) binding protein-3 by breast cancer cell membranes enhances IGF-I binding. Endocrinology 144:4042-4050 (Pubitemid 37088759)
33. Schedlich LJ, Nilsen T, John AP, Jans DA, Baxter RC 2003 Phosphorylation of insulin-like growth factor binding protein-3 by deoxyribonucleic acid-dependent protein kinase reduces ligand binding and enhances nuclear accumulation. Endocrinology 144:1984-1993 (Pubitemid 36543338)
34. Santer FR, Moser B, Spoden GA, Jansen-Dürr P, Zwerschke W 2007 Human papillomavirus type 16 E7 oncoprotein inhibits apoptosis mediated by nuclear insulin-like growth factor-binding protein- 3 by enhancing its ubiquitin/proteasome-dependent degradation. Carcinogenesis 28:2511-2520 (Pubitemid 350238953)
35. Oh Y, Müller HL, Pham H, Rosenfeld RG 1993 Demonstration of receptors for insulin-like growth factor-binding protein-3 on Hs578T human breast cancer cells. J Biol Chem 268:26045-26048 (Pubitemid 23361660)
36. Ahmed K, Davis AT, Wang H, Faust RA, Yu S, Tawfic S 2000 Significance of protein kinase CK2 nuclear signaling in neoplasia. J Cell Biochem Suppl 35:130-135
37. Yu S, Wang H, Davis A, Ahmed K 2001 Consequences of CK2 signaling to the nuclear matrix. Mol Cell Biochem 227:67-71 (Pubitemid 34048369)
38. Meggio F, Pinna LA 2003 One-thousand-and one substrates of protein kinase CK2? FASEB J 17:349-368
39. Liu B, Lee KW, Anzo M, Zhang B, Zi X, Tao Y, Shiry L, Pollak M, Lin S, Cohen P 2007 Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis. Oncogene 26:1811-1819 (Pubitemid 46426204)
40. Granata R, Trovato L, Lupia E, Sala G, Settanni F, Camussi G, Ghidonni R, Ghigo E 2007 Insulin-like growth factor binding protein-3 induces angiogenesis through IGF-I- and SphK1-dependent mechanisms. J Thromb Haemost 5:835-845 (Pubitemid 46563585)
41. Blom N, Gammeltoft S, Brunak S 1999 Sequence- and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 294:1351-1362 (Pubitemid 30008805)
42. Adereth Y, Champion KJ, Hsu T, Dammai V 2005 Site-directed mutagenesis using Pfu DNA polymerase and T4 DNA ligase. Biotechniques 38:864-866 (Pubitemid 41724842)
43. Sell C, Rubini M, Ribom R, Liu J, Efstratiadis A, Baserga R 1993 Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc Natl Acad Sci USA 90:11217-11221 (Pubitemid 23354400)